04.19.2024 First KSF Monthly Lab Meeting Hosts Over 25 Researchers On April 9, 2024, Dr. Clara Tang, KSF Director of Research, facilitated the first global...
11.30.2022 KSF Survey Leads to Planned Expansion of Dietary Clinical Trial In the summer of 2022, the Kabuki Syndrome Foundation hosted its annual crowdsourcing survey. This...
06.14.2022 Kabuki Syndrome Foundation Awards $125,000 to Fund Research at Kennedy Krieger Institute BALTIMORE, June 14, 2022—Dr. Jacqueline Harris, a pediatric neurologist and director of Kennedy Krieger’s Epigenetics...
05.03.2022 ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University MADRID, SPAIN and CAMBRIDGE, MA, UNITED STATES, May 3rd, 2022 – Oryzon Genomics, S.A. (ISIN Code:...
02.28.2022 Kennedy Krieger Patient with Kabuki Syndrome Stars in Episode of ABC’s ‘The Good Doctor,’ Spotlighting This Rare Disease BALTIMORE, February 28, 2022 – A Kennedy Krieger Institute physician and a longtime patient play important roles in an...
02.27.2022 First Kabuki Syndrome Actor Spotlighted in ABC Series, The Good Doctor Mathew Horner is the first actor with Kabuki Syndrome cast in a major network TV...